Publication | Open Access
Drug-Eluting Fibers for HIV-1 Inhibition and Contraception
126
Citations
45
References
2012
Year
Tissue EngineeringEngineeringBiomaterials DesignBiofabricationPharmacotherapyBiomedical EngineeringNanomedicineContraceptionHuman RetrovirusHiv-1 PreventionDrug Delivery SystemHiv-1 InhibitionMultipurpose Prevention TechnologiesHivPharmacologyPolymer-drug ConjugateTreatment And PreventionNanofiber MeshesNano-drug DeliveryMedicineBiocompatible Material
Multipurpose prevention technologies (MPTs) that simultaneously prevent sexually transmitted infections (STIs) and unintended pregnancy are a global health priority. Combining chemical and physical barriers offers the greatest potential to design effective MPTs, but integrating both functional modalities into a single device has been challenging. Here we show that drug-eluting fiber meshes designed for topical drug delivery can function as a combination chemical and physical barrier MPT. Using FDA-approved polymers, we fabricated nanofiber meshes with tunable fiber size and controlled degradation kinetics that facilitate simultaneous release of multiple agents against HIV-1, HSV-2, and sperm. We observed that drug-loaded meshes inhibited HIV-1 infection in vitro and physically obstructed sperm penetration. Furthermore, we report on a previously unknown activity of glycerol monolaurate (GML) to potently inhibit sperm motility and viability. The application of drug-eluting nanofibers for HIV-1 prevention and sperm inhibition may serve as an innovative platform technology for drug delivery to the lower female reproductive tract.
| Year | Citations | |
|---|---|---|
1997 | 2.6K | |
2010 | 2.4K | |
2002 | 1.6K | |
1998 | 1.2K | |
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity Patrick Dorr, Mike Westby, Susan Dobbs, Antimicrobial Agents and Chemotherapy Standard DeviationsImmunologyPharmacotherapyChemokine Receptor Ccr5Antiviral Drug | 2005 | 1.1K |
2002 | 795 | |
2000 | 745 | |
2009 | 624 | |
2011 | 349 | |
2006 | 338 |
Page 1
Page 1